Search Lavipharm.com

 

Regulated Information

Peania, February 21st, 2020 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Dr. Athanase...

Peania, February 14th, 2020 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Dr. Athanase Lavidas, proceeded with the following...

Peania January 31st 2020 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Mr. Athanasios...

  Lavipharm S.A. announces, according to Ν.3556/2007, 1/434/3.7.2007 and Circular 33 of the Board of Directors of the Capital Market Committee, that on 18/5/2009, Μr. Christos Kartalis, son of Dimitrios, Group Chief Commercial Officer of Lavipharm, purchased 70.000 common Lavipharm shares, amounting to 115.000,00 euros....